3//SEC Filing
ARCH Venture Fund IX, L.P. 3
Accession 0000950170-24-037472
CIK 0001782303other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 7:50 PM ET
Size
28.6 KB
Accession
0000950170-24-037472
Insider Transaction Report
Form 3
ARCH Venture Fund IX, L.P.
10% Owner
Holdings
- 27,349(indirect: See footnotes)
Common Stock
- 41,025(indirect: See footnotes)
Common Stock
- (indirect: See footnotes)
Series A Convertible Preferred Stock
→ Common Stock (424,908 underlying) - (indirect: See footnotes)
Series C Convertible Preferred Stock
→ Common Stock (164,835 underlying) - (indirect: See footnotes)
Series A Convertible Preferred Stock
→ Common Stock (454,212 underlying) - (indirect: See footnotes)
Series B Convertible Preferred Stock
→ Common Stock (227,920 underlying) - (indirect: See footnotes)
Series C Convertible Preferred Stock
→ Common Stock (201,465 underlying) - (indirect: See footnotes)
Series C Convertible Preferred Stock
→ Common Stock (366,301 underlying) - (indirect: See footnotes)
Series A Convertible Preferred Stock
→ Common Stock (586,080 underlying)
Footnotes (6)
- [F1]Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX). ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX.
- [F2]Represents shares held directly by ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage). ARCH Venture Partners IX Overage, L.P. (AVP IX Overage LP) is the sole general partner of ARCH IX Overage.
- [F3]ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any.
- [F4]Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage). ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage.
- [F5]ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein., if any.
- [F6]Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
Documents
Issuer
Boundless Bio, Inc.
CIK 0001782303
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001666306
Filing Metadata
- Form type
- 3
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 7:50 PM ET
- Size
- 28.6 KB